Comparison of Tissue Molecular Biomarker Testing Turnaround Times and Concordance Between Standard of Care and the Biocartis Idylla Platform in Patients With Colorectal Cancer
Gregory J. Tsongalis(Dartmouth–Hitchcock Medical Center), Kashyap Patel, William L Skinner(Mercy Health), Mutasim Elfahal(Lahey Medical Center), Stacey S. O’Neill(University of North Carolina at Chapel Hill), Andrew Judd(University of New Mexico), Michael Suriawinata(Dartmouth College), Huiya Huang(Medical College of Wisconsin), Sara E. Atkinson(Cone Health), Heather Colabella(Cancer Treatment Centers of America), Adrian Tira(Rush University Medical Center), Kurtis D. Davies(University of Colorado Anschutz Medical Campus), Edward A. Levine(Wake Forest University), Mohammad A. Vasef(University of New Mexico), Dara L. Aisner(University of Colorado System), György Ábel(Lahey Medical Center), Mark W. Linder(University of Louisville Hospital), Lisa Scicchitano(Geisinger Medical Center), Shuko Harada(University of Alabama at Birmingham), Judy Sequeira(Cancer Treatment Centers of America), Lela Buckingham(Rush University Medical Center), Alexander C. Mackinnon(University of Chicago), Ravikumar Paluri(University of Alabama at Birmingham), Amy Lax(Cone Health), Marcia Cruz‐Correa, Holly N Wood(University of Colorado Anschutz Medical Campus), C. J. Snead(United States Naval Research Laboratory), Gina DeFrank(University of Alabama at Birmingham), Khaled Alkhateeb(University of Louisville Hospital), Sharon M Cavone(Cancer Treatment Centers of America), Arnaldo Rojas, Kristi Mitchell(Analytical Services), Yi Ding(First Affiliated Hospital of Zhengzhou University), Michael J Babcock(Analytical Services), Bradford A. Tan(Cancer Treatment Centers of America), Virginia Ramirez, Fernando U. Garcia(Drexel University), Ralph V. Boccia(Center for Cancer and Blood Disorders), M Rabie Al Turkmani(Dartmouth College)
Cited by 14
Related Papers
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
|Journal of the National Comprehensive Cancer Network|2021|1k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020
|Journal of the National Comprehensive Cancer Network|2019|1k
Non–Small Cell Lung Cancer, Version 4.2024
|Journal of the National Comprehensive Cancer Network|2024|805